Sosei Heptares

    OverviewSuggest Edit

    Sosei Heptares is an international biopharmaceutical company focused on the design and development of new medicines originating from its proprietary GPCR-targeted StaR technology and structure-based drug design platform capabilities. The Company aims to advance a broad and deep pipeline of partnered and wholly owned product candidates in multiple therapeutic areas, including CNS, cancer, metabolic diseases and other rare/specialty indications.

    HQChiyoda City, JP

    Latest Updates

    Employees (est.) (Dec 2018)171

    Key People/Management at Sosei Heptares

    Shinichi Tamura

    Shinichi Tamura

    President, CEO
    Chris Cargill

    Chris Cargill

    EVP, CFO
    Malcolm Weir

    Malcolm Weir

    EVP, Chief R&D Officer
    Show more

    Sosei Heptares Office Locations

    Sosei Heptares has offices in Chiyoda City, Great Abington and London
    Chiyoda City, JP (HQ)
    2-1 Kojimachi
    Great Abington, GB
    Granta Park
    London, GB
    119 Marylebone Road North West House
    Show all (3)

    Sosei Heptares Financials and Metrics

    Sosei Heptares Acquisitions / Subsidiaries

    Acquired CompanyDateDeal Size
    Heptares TherapeuticsFebruary 22, 2015$400 m

    Sosei Heptares Online and Social Media Presence

    Embed Graph

    Sosei Heptares News and Updates

    Sosei Heptares Investor R&D Event Highlights Innovative Research and Development Approaches and Strong Pipeline Momentum

    TOKYO and LONDON, Sept. 12, 2019 /PRNewswire/ -- Sosei Group Corporation ("the Company"; TSE: 4565) today held an Investor R&D Event in Tokyo, Japan, discussing how the integration of its proprietary StaR® technology and approach to AI and machine learning in structure-based drug...

    Sosei Heptares Operational Highlights and Consolidated Results for the First Half of FY2019

    TOKYO and LONDON, Aug. 13, 2019 /PRNewswire/ -- Sosei Group Corporation ("the Company") (TSE: 4565) provides an update on operational activities and reports its consolidated results for the first half of FY2019. The full report can be accessed by clicking here. Operational Highlights...

    Sosei Heptares Frequently Asked Questions

    • When was Sosei Heptares founded?

      Sosei Heptares was founded in 1990.

    • Who are Sosei Heptares key executives?

      Sosei Heptares's key executives are Shinichi Tamura, Chris Cargill and Malcolm Weir.

    • How many employees does Sosei Heptares have?

      Sosei Heptares has 171 employees.

    • Who are Sosei Heptares competitors?

      Competitors of Sosei Heptares include Omeros, Imara and Tanvex Biopharma.

    • Where is Sosei Heptares headquarters?

      Sosei Heptares headquarters is located at 2-1 Kojimachi, Chiyoda City.

    • Where are Sosei Heptares offices?

      Sosei Heptares has offices in Chiyoda City, Great Abington and London.

    • How many offices does Sosei Heptares have?

      Sosei Heptares has 3 offices.